Medicure (CVE:MPH) Shares Pass Below 200 Day Moving Average – Here’s Why

Medicure Inc. (CVE:MPH)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$0.89 and traded as low as C$0.72. Medicure shares last traded at C$0.89, with a volume of 6,996 shares trading hands.

Medicure Price Performance

The company has a quick ratio of 1.29, a current ratio of 2.03 and a debt-to-equity ratio of 4.65. The company has a market cap of C$9.29 million, a PE ratio of -4.57 and a beta of 0.90. The stock has a 50-day simple moving average of C$0.79 and a 200 day simple moving average of C$0.89.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.